What's breaking now, across thousands of outlets.
(MedPage Today) -- An investigational monoclonal antibody targeting dengue virus (Dengue-mAb) safely reduced viral loads and infection symptoms, according to a placebo-controlled phase II trial in India. Among 249 adults hospitalized with dengue...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
Immune checkpoint blockade is a form of cancer treatment that works by releasing the natural brakes on the immune system, allowing T cells to find and destroy cancer cells.
“Changing rainfall patterns and changing temperature patterns create favourable breeding conditions for some of these diseases to thrive,” Consortium Director, Professor Philip Antwi-Agyei stressed.
Older adults with Type 2 diabetes who enrolled in Medicare Advantage plans did not experience better health outcomes, study finds.
Scientists are increasingly interested in how different exercise intensities can trigger different responses in the body. A new study finds that an all out sprint may have unique benefits.
FDA aprova o primeiro wearable que mede cetonas e glicose ao mesmo tempo Revolução para atletas, diabéticos e entusiastas da dieta keto Introdução Imagine poder conferir, a cada 5 minutos, o nível de…
(MedPage Today) -- The FDA authorized the Libre Duo 10 Day Continuous Dual Glucose-Ketone Monitoring System for people ages 2 years and older with diabetes, the agency announced Tuesday.
